» Articles » PMID: 2438450

Human Megakaryocytic Progenitor Cells

Overview
Journal Klin Wochenschr
Specialty General Medicine
Date 1987 Apr 1
PMID 2438450
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

Megakaryocytopoiesis represents one of several differentiation pathways that hematopoietic stem cells may enter. Cells representing intermediate stages of differentiation between pluripotent stem cells and maturing megakaryocytes are called megakaryocytic progenitor cells. They are identified in human bone marrow and peripheral blood by their ability to proliferate in culture (colony forming unit-megakaryocyte, CFU-M); at some point they lose the capacity for cell division and acquire the ability for endoreduplication of DNA, a phenomenon that is unique to the megakaryocyte lineage. This review summarizes current understanding of the biology of human megakaryocytic progenitor cells, including characterization of their proliferation potentials, their antigenic determinants, and the mechanisms that govern their proliferation and maturation. Finally the involvement of CFU-M in various disorders of thrombopoiesis is discussed.

Citing Articles

Platelets and cancer: a casual or causal relationship: revisited.

Menter D, Tucker S, Kopetz S, Sood A, Crissman J, Honn K Cancer Metastasis Rev. 2014; 33(1):231-69.

PMID: 24696047 PMC: 4186918. DOI: 10.1007/s10555-014-9498-0.


A natural-like synthetic small molecule impairs bcr-abl signaling cascades and induces megakaryocyte differentiation in erythroleukemia cells.

Turroni S, Tolomeo M, Mamone G, Picariello G, Giacomini E, Brigidi P PLoS One. 2013; 8(2):e57650.

PMID: 23460890 PMC: 3584047. DOI: 10.1371/journal.pone.0057650.


[Demonstration of thrombocyte membrane proteins with monoclonal antibodies by a flow cytometry bioassay].

Tschope D, Schauseil S, Roesen P, Kaufmann L, Gries F Klin Wochenschr. 1988; 66(3):117-22.

PMID: 3352192 DOI: 10.1007/BF01774225.


[Hematologic or hemostaseologic "paraneoplastic syndromes" as prognostic factors?].

Schneider W Klin Wochenschr. 1988; 66(3):103-9.

PMID: 3280868 DOI: 10.1007/BF01774223.


Increased platelet volume--sign of impaired thrombopoiesis in diabetes mellitus.

Tschope D, Langer E, Schauseil S, Rosen P, Kaufmann L, Gries F Klin Wochenschr. 1989; 67(4):253-9.

PMID: 2927060 DOI: 10.1007/BF01717328.


References
1.
Vainchenker W, Chapman J, Deschamps J, Vinci G, Bouguet J, Titeux M . Normal human serum contains a factor(s) capable of inhibiting megakaryocyte colony formation. Exp Hematol. 1982; 10(8):650-60. View

2.
Hoffman R, Bruno E, Elwell J, Mazur E, Gewirtz A, Dekker P . Acquired amegakaryocytic thrombocytopenic purpura: a syndrome of diverse etiologies. Blood. 1982; 60(5):1173-8. View

3.
Sanderson C, Warren D, Strath M . Identification of a lymphokine that stimulates eosinophil differentiation in vitro. Its relationship to interleukin 3, and functional properties of eosinophils produced in cultures. J Exp Med. 1985; 162(1):60-74. PMC: 2187704. DOI: 10.1084/jem.162.1.60. View

4.
Eaves A, Eaves C . Erythropoiesis in culture. Clin Haematol. 1984; 13(2):371-91. View

5.
Bennett J, Catovsky D, Daniel M, Flandrin G, GALTON D, Gralnick H . Criteria for the diagnosis of acute leukemia of megakaryocyte lineage (M7). A report of the French-American-British Cooperative Group. Ann Intern Med. 1985; 103(3):460-2. DOI: 10.7326/0003-4819-103-3-460. View